SETDB1 and glioblastoma: We performed protein turnover assays and the results suggested that TRAF4 knockdown can effectively reduce the stability of SETDB1 in glioblastoma cells treated with de novo protein synthesis inhibitor cycloheximide (CHX) (Figure 6B,C).